Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
26.59
+0.37 (1.39%)
Nov 21, 2024, 1:24 PM EST - Market open
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $15.66 billion as of November 21, 2024. Its market cap has increased by 26.65% in one year.
Market Cap
15.66B
Enterprise Value
21.65B
1-Year Change
26.65%
Ranking
Category
Stock Price
$26.59
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has decreased from $15.76B to $15.66B, a decrease of -0.62%. That is a compound annual growth rate of -0.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 11.65B | -6.78% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molina Healthcare | 16.71B |
| United Therapeutics | 16.04B |
| Viatris | 15.52B |
| ICON Public Limited Company | 15.46B |
| Moderna | 15.20B |
| Incyte | 14.83B |
| Tenet Healthcare | 14.59B |
| Summit Therapeutics | 14.00B |